Loading...
Loading...
DNA| Name | Value |
|---|---|
| Revenues | 56.2M |
| Cost of Revenue | 31.1M |
| Gross Profit | 25.2M |
| Operating Expense | 267.3M |
| Operating I/L | -222.9M |
| Other Income/Expense | 6.0M |
| Interest Income | 10.3M |
| Pretax | -217.0M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -217.2M |
Ginkgo Bioworks Holdings, Inc. develops a cell programming platform used to engineer cells for the biological production of various products, including therapeutics, food ingredients, and chemicals. The company caters to markets such as specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop the ImmTOR technology platform, which enhances its capabilities in the biotechnology sector.
